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Abstract
The aim of this study was to determine the effects of levamisole on sperm characteristics and
hyaluronidase activity of blood serum and semen. For this purpose, 12 Akkaraman rams (2–3 years
old) were used. Levamisole hydrochloride was administered orally at a dose of 7.5 mg/kg body
weights once daily for 2 days. Serum and semen samples were collected from the rams at post-
treatment 1, 2, 4, 24, 48, 72, 96, 120, 144, 216, 288 and 384 h and examined for sperm characteristics
and hyaluronidase activity. The results showed that the use of levamisole caused significant
(P < 0:01) increase in serum hyaluronidase activity at all times except the 72 h, and in semen
hyaluronidase activity at 1, 2, 4, 24, 72, 96 and 120 h compared to the control group. In addition, the
levamisole caused significant (P < 0:05) decreases in semen volume, sperm motility, concentration
and total sperm number at all times. There was no correlation between semen hyaluronidase activity
and the sperm characteristics. In conclusion, levamisole did not have any deleterious effect on
hyaluronidase enzyme. However, the use of this drug in rams during the breeding season is harmful
due to the decrease of sperm characteristics.
# 2003 Elsevier Inc. All rights reserved.
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1. Introduction
Levamisole is highly acceptable anti-nematodal drug because of its broad range of
activity in a large number of hosts (sheep, cattle, pig, horse, chicken, dog) [1]. It is known
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that this drug stimulates cells mediated immune reactivity by potentiating the rate of
T-lymphocyte differentiation and proliferation of macrophages [2]. Furthermore, levami-
sole is used to treat the chronic infection, inflammatory disease and some malignancies [3].
It has been reported that alkaline phosphatase inhibitor levamisole decreases the produc-
tion of dihydrotestosterone in fibroblasts [4–6].
Hyaluronic acid is a component of extracellular matrix that holds the follicular cells
together and degraded by hyaluronidase enzyme released from sperm head during
acrosomal reaction [7–9]. It is also synthesized in the cellular plasma membrane of
leukocytes, neutrophiles and fibroblasts and rapidly degraded in the lysosomes by
hyaluronidase to lactate and acetate [10]. It was reported that hyaluronic acid levels in
serum are elevated during infections and this elevation may be a clinically useful marker of
the increased inflammatory activity [11]. The deficiency in hyaluronidase activity of serum
causes the elevation of hyaluronic acid in serum 38–90 folds over normal and it can be fatal
[12].
Semen hyaluronidase activity could be an index of fertilization ability [13] and there is
no published report on the effects of levamisole on sperm characteristics and hyalur-
onidase activity of serum and semen. Levamisole are commonly in veterinary practice
in Turkey. The objective of this study was to evaluate the effects of levamisole on sperm
characteristics and hyaluronidase activity of serum and semen in rams, and to deter-
mine whether there is a relationship between semen hyaluronidase activity and sperm
characteristics.
2. Materials and methods
2.1. Chemicals and drugs
Levamisole hydrochloride (Nilverm Fort poudre, Sanofi, İstanbul) was used. The other
chemicals were purchased from Sigma (St. Louis, MO, USA).
2.2. Animals, drugs administration and sample collection
Twelve Akkaraman rams (2–3 years old) were used in the present study. The rams were
fed on grass supplemented with lucerne hay, and drinking water was provided adlibitum.
The rams were randomly divided into two groups. These groups were assigned as a control
(n ¼ 4) and treatment (n ¼ 8). Serum and semen hyaluronidase activity and sperm
characteristics of all rams in each group were determined prior to drug injection.
Levamisole hydrochloride was dissolved in 20 ml distilled water and administered orally
at a dose of 7.5 mg/kg body weight, in morning once daily for 2 days in breeding season.
This oral dose is recommended against nematodes in sheep. Twenty milliliters of distilled
water was administered orally to the control rams.
After the last drug administration blood samples were collected from jugular vein and
semen samples were taken by using artificial vagina from all rams at 1, 2, 4, 24, 48, 72, 96,
120, 144, 216, 288 and 384 h. The mean residence time of levamisole in sheep has been
found to be about 216 h [1].
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2.3. Assays
Semen volume was determined by direct reading the graduations of collection tubes
(from 0.1 to 10 ml). Sperm concentration was determined with a heamocytometer. Semen
samples were decimally diluted with isotonic sodium citrate solution at 37 8C (3%, w/v,
dissolved in distilled water) at the rate of 1:10. A slide was placed on phase contrast
microscope and allowed to warm up to 37 8C, and then a small droplet of diluted semen was
placed on the slide and percent motility was evaluated visually at a magnification of 400.
Motility estimations were performed from three different fields in each sample. The mean
of the three estimations was used as the final motility score [14].
Hyaluronidase activity of fresh whole semen was measured using the methods described
by Tanyıldızı and Bozkurt [15] and Joyce et al. [16]. The serum and semen samples were
diluted 1:5 with 0.15 mol/l sodium chloride before assay. One milliliter of diluted samples
was added to 0.1 ml acetate buffer (0.3 mol/l, contained 0.45 mol/l sodium chloride) and
0.1 ml hyaluronic acid substrate (4 mg hyaluronic acid was dissolved in 1 l water) was
added to these mixtures and then incubated for 24 h at 37 8C in a temperature controlled
room. After the reaction mixtures were taken, 60 ml potassium tetraborate (0.8 mol/l in
water, pH ¼ 10) was added, and reaction was terminated by heating block for 5 min. Then,
the mixtures were cooled in an ice-water bath before adding 2 ml of p-dimethylamino-
benzaldehyde (Stock DMAB reagent, 10%, w/v, in 12.5%, v/v, concentrated hydrochloric
acid in glacial acetic acid: stock reagent diluted 1 in 10 with glacial acetic acid before use)
and then incubated for 20 min at 37 8C in a water bath. The reaction mixtures were
centrifuged immediately at 1500  g for 10 min and the absorbance of the supernatant read
at 582 nm within 30 min using a spectrophotometer. N-Acetylglucosamine was used as a
standard and was reacted with p-dimethylaminobenzaldehyde as describe above.
2.4. Statistical analysis
The data are presented as the mean  S:E:M. Chi-square analysis was used to determine
differences in the sperm motilities between control and treatment groups. Non-parametric
Mann–Whitney U test was applied to determine statistically significant differences
between control and treatment groups. To determine the differences between time points
post hoc comparisons were made with Duncan’s multiple comparison test. Spearman rank
correlation test was used to determine the relationship between the hyaluronidase activity
of semen and sperm characteristics. All analyses were carried out by SPSS statistical
program (Win 6.0).
3. Results
The differences in sperm characteristics and hyaluronidase activity of serum and semen
before the administration of levamisole between animals in control and treatment groups
were not significant (P > 0:05) (Table 1).
The differences in serum hyaluronidase activity between control and treatment
groups were shown in Table 1. Levamisole increased significantly (P < 0:01) the serum
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hyaluronidase activity at all times except the 72 h (Table 1). A significant (P < 0:01)
decrease was observed at 72 h. The differences in semen hyaluronidase activity between
control and treatment groups were shown in Table 1. The administration of levamisole
caused significant (P < 0:01) increases in the semen hyaluronidase activity at 1, 2, 4, 24,
72, 96 and 120 h (Table 1). However, levamisole therapy caused significant (P < 0:05)
decreases in semen volume, sperm motility, sperm concentration and total sperm number
(Table 2) at all times when compared with the control group. There was no correlation
between semen hyaluronidase activity and sperm characteristics.
4. Discussion
Levamisole is effective against nematodes of the lungs and gastro-intestinal tract. It was
reported that testosterone production of leydig cells is inhibited by levamisole [17].
Testosterone is required physiologically for the completion of meiosis and spermiogenesis
in testes [18]. Additionally, fluid secretion by the sertoli cells also commences into the
tubular lumen and is regulated by testosterone [19,20]. The findings of this study revealed
that treatment of levamisole caused significant (P < 0:01) decreases in the sperm con-
centration and semen volume in rams. These decreases may be occurs from the effect of
this drug to epididymal contractile elements and accessory glands.
Kavanagh et al. [21] reported that levamisole inhibited sperm motility due to it is a
potent inhibitor of seminal diamino oxidase. The results of this study showed that treatment
Table 1
Hyaluronidase activities of serum and semen in rams treated with levamisole
Time (h) Groups
Serum
control (n ¼ 4)
Serum
treatment (n ¼ 8)
Semen
control (n ¼ 4)
Semen
treatment (n ¼ 8)
Pre-treatment values 59.0  4.2 51.6  3.8 21.1  3.5 26.2  2.5
1 68.7  3.2A 144.8  4.7a,B 20.2  1.4A 48.2  2.7a,B
2 65.2  2.8A 169.4  5.3b,B 21.4  1.3A 50.1  3.5a,B
4 67.1  2.1A 170.5  4.3b,B 23.8  1.9A 55.7  3.2a,B
24 71.0  2.5A 176.2  5.6b,B 19.4  1.8A 60.1  3.9b,B
48 65.2  2.3A 149.4  4.9A,b 20.8  1.9 25.1  1.1c
72 66.1  2.4A 38.8  2.1d,B 23.8  2.2A 51.5  2.7a,B
96 68.3  2.8A 138.1  5.5a,B 22.4  1.2A 67.3  3.2b,B
120 63.0  2.5A 122.2  4.3a,B 20.3  1.1A 50.1  2.9a,B
144 69.1  2.1A 135.1  3.6a,B 21.1  1.5 27.5  1.2c
216 70.2  2.9A 102.2  3.4c,B 22.2  1.8 24.9  1.9c
288 68.1  2.3A 109.6  3.3c,B 21.1  1.5 26.6  1.4c
384 67.3  2.3A 107.3  3.6c,B 22.2  1.9 25.1  1.5c
Mean 67.4  0.6A 130.3  11.0a,B 21.6  0.4A 42.7  4.5a,B
Values with different lower case (a, b, c and d) in the same column differ significantly (P < 0:05).
Different upper case letters (A and B) within same line showed significant (P < 0:01) differences control and
treatment groups.
The activity was expressed as the mean (S.E.M.) mmol NAG/min/l.
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Table 2










0.80  0.03 0.92a,A  0.04 0.88a,b,A  0.05 0.93a,A  0.04 0.81b,A  0.08 0.83b,A  0.05 0.90a,A  0.07 0.82b,A  0.03 0.87a,b,A  0.05 0.93a,A  0.02 0.88a,b,A  0.01
Treatment
(n ¼ 8)




2.52  0.02 2.42a,A  0.01 2.19b,c,d,A  0.03 2.10b,c,e,A  0.02 2.24b,c,d,A  0.05 2.34a,d,A  0.05 2.09c,e,A  0.03 2.00e,A  0.02 2.11b,e,A  0.01 2.07b,e,A  0.04 2.21b,c,d,A  0.04
Treatment
(n ¼ 8
2.30  0.03 1.68a,e,B  0.01 1.66a,e,B  0.05 1.81a,B  0.01 1.25b,c,B  0.03 1.42b,B  0.03 1.35b,d,B  0.02 1.09c,B  0.06 1.28b,c,B  0.05 1.16c,d,B  0.01 1.56e,B  0.10
Total sperm number (109)
Control
(n ¼ 4)
2.01  0.02 2.22a,A  0.04 1.92b,A  0.03 1.95a,A  0.02 1.81b,c,A  0.03 1.94b,A  0.05 1.88b,A  0.01 1.64c,A  0.02 1.83b,c,A  0.01 1.92b,A  0.02 1.90b,A  0.05
Treatment
(n ¼ 8)




76.1  1.1 75.4A  1.6 72.6A  2.3 74.6A  4.1 78.3A  1.7 75.5A  2.0 80.9A  2.8 80.7A  1.5 82.8A  2.6 81.9A  1.5 77.7A  0.9
Treatment
(n ¼ 8)
75.3  1.0 65.0B  1.6 60.2B  3.0 63.2B  2.7 70.8B  3.8 65.0B  2.1 70.0B  1.4 70.3B  3.5 71.1B  1.7 69.4B  2.5 65.8B  1.2
Hours post-treatment.
Different lower case letters (a, b, c, d and e) within same line indicate significant (P < 0:05) differences.
Different upper case letters (A and B) within same column showed significant (P < 0:05) differences between control and treatment groups.



































with levamisole of rams caused significant (P < 0:05) decreases in the sperm motility. The
inhibition of sperm motility showed that levamisole could cause a decrease in the sperm
motility depending on the inhibition of diamino oxidase in seminal plasma.
Acrosomal enzymes play an essential role in fertilization and hyaluronidase being
among the acrosomal enzymes is particularly important in dispersing cumulus cells [5]. It
was also reported that the low hyaluronidase activity causes a decrease in fertilizing
capability of sperm [22]. The findings of this study indicate that levamisole caused
significant (P < 0:001) increases in the semen hyaluronidase activity of rams at 1, 2,
4, 24, 72, 96 and 120 h. The elevation of semen hyaluronidase activity may be explained
with the movement of hyaluronidase from serum to seminal plasma. However, the
hyaluronidase activity of semen at 48, 144, 216, 288 and 384 h did not change compared
to the control group due to 6 h of the biological half life of levamisole in plasma and mean
residence time of this drug in body about 216 h [1]. The cause of the decrease of semen
hyaluronidase activity in treatment group at 48 h is not known. Further studies are required
for explanation of this decrease.
It was reported that levamisole increases the release of hyaluronidase from macrophages
and neutrophiles [23,24]. The results of this study showed that levamisole caused
significant (P < 0:01) increases in the serum hyaluronidase activity of rams at all times
except the 72 h. The cause of the decrease of serum hyaluronidase activity at 72 h is
unknown. Further studies are required for explanation of this decrease at this time. This
elevation may indicate that levamisole increases serum hyaluronidase activity in sheep
depending on the increase of hyaluronidase releasing by macrophages and neutrophiles.
Additionally, levamisole is used during chronic bacterial disease and inflammatory disease
[2] and hyaluronic acid levels in serum are increased during infections [8]. A deficiency in
hyaluronidase activity of serum causes to the elevation of hyaluronic acid in serum 38–90
fold over normal and it is incompatible with life [12]. After treatment with levamisole of
rams, the elevation of hyaluronidase activity in serum is a beneficial effect for body due to
the degradation of hyaluronic acid by serum hyaluronidase.
In conclusion, the findings of this study indicate that levamisole increases hyaluronidase
activity in serum and semen. Besides, it causes significant decreases in semen volume,
sperm motility, concentration and total sperm number in rams. Despite some reported
benefits of elevated hyaluronidase activity, our observation, indicate that levamisole was
found to be clearly detrimental to semen quality. For this reason, the use of levamisole is
not suitable during breeding season in rams.
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